News Analysis: German pharma industry grows, but patent, tariff pressures cloud outlook

BERLIN, Jan. 14 (Xinhua) -- Parts of Germany's health and life sciences industry, led by research-driven pharmaceutical companies, have continued to hire, invest, and expand, even as the broader manufacturing economy struggles to regain momentum.

However, this export-oriented sector, despite its counter-trend growth, is facing mounting pressures, including a wave of patent expirations for top-selling drugs and higher tariffs imposed by the United States.